PDCD1 and melanoma: Arguably, TYRO3 could serve as a predictive biomarker for patient selection and a promising therapeutic target to overcome anti-PD-1/PD-L1 resistance.52 Similarly, our data illustrated the regulatory mechanism of melanoma cell ferroptosis from the perspective of miRNAs modulation by obtaining the expression profile of miRNAs.